Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-24

FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

The FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole, authorizing a generic ARIPIPRAZOLE product with the same indications as the bra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)